Literature DB >> 21626105

Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.

Keiko Nomura1, Hirokazu Kanegane2, Keisuke Otsubo1, Hiroshi Wakiguchi3, Yukihiro Noda4, Yoshihito Kasahara5, Toshio Miyawaki1.   

Abstract

Chronic active Epstein-Barr virus infection (CAEBV) is defined as a systemic EBV-associated lymphoproliferative disease characterized by fever, lymphadenopathy, and splenomegaly in apparently immunocompetent persons. Recent studies have revealed that EBV infects T or natural killer cells in most patients with CAEBV; the etiology of CAEBV, however, remains unknown. Autoimmune lymphoproliferative disorder (ALPS) is an inherited disorder associated with defects in apoptosis, and clinically characterized by lymphadenopathy, splenomegaly, hypergammaglobulinemia, and autoimmune disease. ALPS is most often associated with mutations in the FAS gene, which is an apoptosis-signaling receptor important for homeostasis of the immune system. Based on the clinical similarity between ALPS and CAEBV with respect to lymphoproliferation, we have examined the possibility of the co-occurrence of ALPS in patients with a diagnosis of CAEBV. In this study, we have identified FAS gene mutations in three Japanese patients with lymphadenopathy, hepatosplenomegaly, and unusual EBV infection, who were diagnosed with CAEBV. These observations, which indicate that the clinical development of ALPS may be associated with EBV infection, alert us to a potential diagnostic pitfall of CAEBV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626105     DOI: 10.1007/s12185-011-0877-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS).

Authors:  P D Arkwright; F Rieux-Laucat; F Le Deist; R F Stevens; B Angus; A J Cant
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Viral interleukin-10 in chronic active Epstein-Barr virus infection.

Authors:  H Kanegane; H Wakiguchi; C Kanegane; T Kurashige; G Tosato
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

4.  Dominant expression of interleukin 10 but not interferon gamma in CD4(-)CD8(-)alphabetaT cells of autoimmune lymphoproliferative syndrome.

Authors:  Shouichi Ohga; Akihiko Nomura; Yasushi Takahata; Kenji Ihara; Hidetoshi Takada; Hiroshi Wakiguchi; Yuji Kudo; Toshiro Hara
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

Review 5.  Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection.

Authors:  Motohiko Okano; Keisei Kawa; Hiroshi Kimura; Akihiro Yachie; Hiroshi Wakiguchi; Akihiko Maeda; Shosuke Imai; Shouichi Ohga; Hirokazu Kanegane; Shigeru Tsuchiya; Tomohiro Morio; Masaaki Mori; Shumpei Yokota; Shinsaku Imashuku
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

6.  Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.

Authors:  J Wang; L Zheng; A Lobito; F K Chan; J Dale; M Sneller; X Yao; J M Puck; S E Straus; M J Lenardo
Journal:  Cell       Date:  1999-07-09       Impact factor: 41.582

7.  Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.

Authors:  I J Fuss; W Strober; J K Dale; S Fritz; G R Pearlstein; J M Puck; M J Lenardo; S E Straus
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

8.  FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.

Authors:  Aude Magerus-Chatinet; Marie-Claude Stolzenberg; Maria S Loffredo; Bénédicte Neven; Catherine Schaffner; Nicolas Ducrot; Peter D Arkwright; Brigitte Bader-Meunier; José Barbot; Stéphane Blanche; Jean-Laurent Casanova; Marianne Debré; Alina Ferster; Claire Fieschi; Benoit Florkin; Claire Galambrun; Olivier Hermine; Olivier Lambotte; Eric Solary; Caroline Thomas; Francoise Le Deist; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  Blood       Date:  2009-01-27       Impact factor: 22.113

9.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

10.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.

Authors:  A J Coffey; R A Brooksbank; O Brandau; T Oohashi; G R Howell; J M Bye; A P Cahn; J Durham; P Heath; P Wray; R Pavitt; J Wilkinson; M Leversha; E Huckle; C J Shaw-Smith; A Dunham; S Rhodes; V Schuster; G Porta; L Yin; P Serafini; B Sylla; M Zollo; B Franco; A Bolino; M Seri; A Lanyi; J R Davis; D Webster; A Harris; G Lenoir; G de St Basile; A Jones; B H Behloradsky; H Achatz; J Murken; R Fassler; J Sumegi; G Romeo; M Vaudin; M T Ross; A Meindl; D R Bentley
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

View more
  7 in total

Review 1.  Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors:  Pu Li; Ping Huang; Ye Yang; Mu Hao; Hongwei Peng; Fei Li
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation.

Authors:  Yi Xie; Stefania Pittaluga; Susan Price; Mark Raffeld; Jamie Hahn; Elaine S Jaffe; V Koneti Rao; Irina Maric
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

3.  Autoimmune Lymphoproliferative Syndrome and Epstein-Barr Virus-Associated Lymphoma: An Adjunctive Diagnostic Role for Monitoring EBV Viremia?

Authors:  Romina Pace; Donald C Vinh
Journal:  Case Reports Immunol       Date:  2013-07-25

Review 4.  Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System.

Authors:  Mario E Cruz-Muñoz; Ezequiel M Fuentes-Pananá
Journal:  Front Microbiol       Date:  2018-01-05       Impact factor: 5.640

Review 5.  Autoimmune lymphoproliferative syndrome: more than a FAScinating disease.

Authors:  Karen Bride; David Teachey
Journal:  F1000Res       Date:  2017-11-01

Review 6.  Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods.

Authors:  Ayako Arai
Journal:  Microorganisms       Date:  2021-01-15

7.  Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge.

Authors:  Aleksandra Szczawińska-Popłonyk; Elzbieta Grześk; Eyal Schwartzmann; Anna Materna-Kiryluk; Jadwiga Małdyk
Journal:  Front Pediatr       Date:  2021-12-30       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.